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The Mycobacterium tuberculosis (Mtb) genome
encodes approximately 90 toxin-antitoxin protein
complexes, including three RelBE family members,
which are believed to play a major role in bacterial
fitness and pathogenicity. We have determined the
crystal structures of Mtb RelBE-2 and RelBE-3, and
the structures reveal homologous heterotetramers.
Our structures suggest RelE-2, and by extension
the closely related RelE-1, use a different catalytic
mechanism than RelE-3, because our analysis of
the RelE-2 structure predicts additional amino acid
residues that are likely to be functionally significant
and are missing from analogous positions in the
RelE-3 structure. Toxicity assays corroborate our
structural findings; overexpression of RelE-3, whose
active site is more similar to Escherichia coli YoeB,
has limited consequences on bacterial growth,
whereas RelE-1 and RelE-2 overexpression results
in acute toxicity. Moreover, RelE-2 overexpression
results in an elongated cell phenotype inMycobacte-
rium smegmatis and protects M. tuberculosis
against antibiotics, suggesting a different functional
role for RelE-2.
INTRODUCTION
Toxin-antitoxin (TA) systems were initially identified as important
mediators of the stability of low-copy plasmids and of bacterio-
phage genomes in bacterial cells (Ogura and Hiraga, 1983;
Gerdes et al., 1986). Similar systems have since been identified
on the chromosomes of many archaea and bacteria, where they
are believed to mediate an organism’s response to physiological
stresses (Pandey and Gerdes, 2005; Makarova et al., 2009).
Typically, TA genes are organized as operons in which the first
open reading frame (ORF) usually encodes an antitoxin and the
second ORF encodes its cognate toxin (Van Melderen et al.,Structure 211994). Under optimal physiological conditions, the toxin and
antitoxin form a stable complex that has no deleterious effects
on the bacterial cell. Environmental stress, such as starvation,
elevated temperature, or antibiotic exposure, can result in the
proteolytic degradation of the labile antitoxin, allowing the stable
toxin to exert a bacteriostatic or bacteriocidal effect on the
bacterium (Pandey and Gerdes, 2005). Many families of toxins
have been identified and each family appears to have a distinct
mechanism by which it affects cellular growth, although there
is considerable overlap in the cellular processes that are tar-
geted for disruption. For instance, both the RelBE and MazEF
systems target protein synthesis but use distinct mechanisms;
RelE toxins inhibit translation in a ribosome-dependent manner
by cleaving messenger RNAs (mRNAs) positioned at the ribo-
somal A-site (Pedersen et al., 2003; Christensen-Dalsgaard
and Gerdes, 2008), whereas MazF degrades free mRNA (Zhang
et al., 2003). Whereas toxins have a sole function (i.e., to mediate
toxicity), antitoxins have the dual function of neutralizing the
toxin through a C-terminal protein-protein interaction domain
and acting as regulatory systems of their own TA operon through
their N-terminal DNA-binding domain (Li et al., 2008).
The regulation of microbial physiology by TA systems has
been widely discussed and many possible functions for TA
systems have been proposed. However, the hypothesis that
TA systems invoke a reversible bacteriostatic state in response
to adverse environmental conditions has become more preva-
lent. The complete range of environmental stresses that activate
TA systems is unknown, but the most biomedically significant
may be bacterial persistence upon antibiotic exposure (Va´z-
quez-Laslop et al., 2006; Maisonneuve et al., 2011).
The Mycobacterium tuberculosis (Mtb) genome contains
about 90 TA systems, which may correlate with its propensity
for persistence, a well-known phenomenon in human tubercu-
losis infections (Pandey and Gerdes, 2005; Ramage et al.,
2009). The distribution of TA systems within the Mtb genome is
markedly biased toward one particular TA system superfamily,
the VapBC family, with over 45 of these systems present for
which a growing number of structures are available (Miallau
et al., 2009; Min et al., 2012). The remaining systems include
members of the MazEF, HigBA, ParDE, and RelBE families.
There are three representatives of the RelBE family encoded in, 627–637, April 2, 2013 ª2013 Elsevier Ltd All rights reserved 627
Table 1. Data Collection Statistics for Mtb RelBE-2 and RelBE-3 TA Complexes
Data Collection RelBE-2 (SeMet Labeled) RelBE-3 (SeMet Labeled) RelBE-3 (Native)
Wavelength (A˚) 0.9793 0.9717 0.9717
Resolution (A˚) 2.0 2.5 2.15
Space group P212121 C2 P21
Unit cell a = 75.5 A˚, b = 79.5 A˚ a = 135.9 A˚, b = 41.2 A˚, c = 68.8 A˚ a = 42.2 A˚, b = 187.3 A˚, c = 113.9 A˚
c = 86.3 A˚ b = 95.5 b = 94.4
Completeness (%) 95.9 (100) 94.4 (93.9) 89.8 (90.4)
Multiplicity 12.6 (13.0) 1.8 (1.8) 2.2 (2.1)
<I >/< s(I)> 19.8 (4.6) 13.9 (5.5) 11.5 (1.9)
Rsym (%) 12.6 (54.3) 3.3 (11.3) 5.3 (40.2)
Number of selenium atoms per
asymmetric unit
Two observed of eight expected Three observed of ten expected
Numbers in parentheses refer to a high-resolution bin of approximate width 0.09 A˚.
Structure
Proteomics of the Three Mtb RelBE TA ComplexestheMtb genome (Rv1246c-Rv1247c, RelBE-1; Rv2865-Rv2866,
RelBE-2; and Rv3357-Rv3358, RelBE-3) and expression of the
toxins upon infection of human macrophages and inhibition of
bacterial growth within the macrophage has been shown (Korch
et al., 2009). Amino acid starvation results in proteolytic degrada-
tion of the RelB-like antitoxin by Lon protease and has two
effects: first, degradation of RelB leads to activation of the
transcription of the RelBE operon, and second, unsequestered
RelE arrests cell growth through ribosome-dependent mRNA
cleavage (Christensen and Gerdes, 2003; Korch et al., 2009).
These toxins have also been linked to the development of
Escherichia coli persisters resistant to a high dosage of anti-
biotics (Keren et al., 2004). Understanding the structure and
function of theMtb RelBE systems may reveal potential vulnera-
bilities of the Mtb cell and allow disruption of bacterial growth
patterns, thus decreasing overall bacterial fitness.
Here, we present the crystal structures of theMtbRelBE-2 and
RelBE-3 complexes and a sequence comparison with RelBE-1.
We show that all three toxins, RelE-1, RelE-2, and RelE-3, are
functional and expressed during Mtb H37Rv infection of human
macrophages. Our crystal structures reveal molecular details of
TA interactions and show how the three RelBE TA systems dif-
ferentially regulate Mtb growth and survival under various con-
ditions. Our results highlight potential functional differences
between toxins of the same superfamily and provide insight
into the role of RelE toxins in promoting bacteriostasis, and
hence survival, under adverse conditions.
RESULTS
Expression of Homologous Mtb RelE Toxins in
Mycobacterium smegmatis Results in Differential Cell
Growth Modulation
The electroporated M. smegmatis cells had two distinct cell
growth characteristics (Figure S1 available online). Cells har-
boring the RelE-3-containing plasmid grew normally in the
absence of the inducing agent and displayed a marked inhibition
of growth in the presence of inducer characterized by the almost
complete absence of colonies on the plates (Figure S1). In
contrast, expression of the RelE-1 and RelE-2 toxins was highly
toxic and no bacterial growth was observed on either the unin-628 Structure 21, 627–637, April 2, 2013 ª2013 Elsevier Ltd All rightsduced or induced plates, indicating that the leakiness of the
promoter allowed a sufficient amount of toxin to be produced
to inhibit cell growth (Figure S1). Control experiments in which
the expression constructs were electroporated into theM. smeg-
matis mc2155 strain, which lacks the T7 polymerase gene, dis-
played normal growth (data not shown), indicating that the
growth phenotypes are toxin specific. Moreover, the observed
toxin-mediated growth inhibition was alleviated by simultaneous
expression of the antitoxins with their cognate toxins, indicating
that growth inhibition is toxin specific and is not a nonspecific
effect attributable to protein overexpression.
Crystal Structures of theMtb RelBE-2 and RelBE-3
Complexes
The Mtb RelE-like toxins are expected to have similar folds and
characteristics based on a high percentage of sequence identity
(RelE1-2 = 55%; RelE1-3 = 31%; RelE2-3 = 33%) (Figure S3).
Because the cell-growth assays determined that RelE-1 and
RelE-2 toxins are significantly more toxic than RelE-3 toxins,
crystallographic studies were initiated to determine the struc-
tural basis of the differences in toxin toxicity. The structures of
the RelBE-2 and RelBE-3 TA complexes were determined by
selenomethionine (SeMet) single-wavelength anomalous diffrac-
tion (SAD) at a resolution of 2.0 and 2.5 A˚, respectively (Supple-
mental Information). The RelBE-2 and RelBE-3 structures have
excellent geometries. Data collection and refinement statistics
are summarized in Tables 1 and 2.
The RelBE-2 and RelBE-3 TA complexes are tetrameric
complexes of two toxins and two antitoxins. In each complex,
one antitoxin binds a single toxin and the heterotetramer is
formed almost exclusively by interactions between the antitoxins
(Figure 1).
RelE-2 and RelE-3 toxins have a similar fold with a three-
stranded b sheet surrounded by two a helices and a 310 helix
as the core structural element (Figure 2A). A structural compar-
ison of theMtb RelE-like toxins with proteins of known structure
confirmed the prediction that the Mtb RelE-like toxins are
members of the RelE/YoeB superfamily (see below for a detailed
comparison).
The crystal structures of the RelB-2 and RelB-3 antitoxins
reveal that these antitoxins have the same two-domain structurereserved
Table 2. Refinement Statistics forMtb RelBE-2 and RelBE-3 TA
Complexes
Refinement RelBE-2 RelBE-3
Total number of molecules (toxin:
antitoxin) per asymmetric unit
4 (2:2) 16 (8:8)
Protein residues 352 out of 420 1,356 out of
1,400 + tags (168)
Solvent molecules 173 439
Heteroatoms 40 0
Rwork/Rfree (%) 20.3/24.6 21.5/26.1
Rmsd bond lengths (A˚)/bond
angles ()
0.017/1.497 0.008/1.074




Favored regions 94.4 96.9
Additionally allowed regions 4.9 3.1
Generously allowed regions 0.7 0.0
Disallowed regions 0.0 0.0
Structure
Proteomics of the Three Mtb RelBE TA Complexesas members of the YefM antitoxin family (Kamada and Hanaoka,
2005; Kedzierska et al., 2007; Kumar et al., 2008). The N-terminal
domain is a globular structure composed of a three-stranded
b sheet surrounded by a helices a-1 and a-2 that extends into
the C-terminal a-helical toxin-neutralization domain composed
of a helices a-3, a-4, and a-5 (Figures 1A, 1F, and 2B).
Interactions between toxins and antitoxins in both the RelBE-2
and RelBE-3 complexes are mediated by antitoxin helices a-3,
a-4, and a-5 with their respective toxins. The helices form an
arm that surrounds the toxins and buries 30% of the toxin’s
total surface area. These interactions are primarily electrostatic
and involve numerous arginine residues from the toxins interact-
ing with acidic antitoxin residues (Figures 1A, 1D, 1F, and 1I).
The two RelBE-2 and RelBE-3 heterodimers assemble with
C2 symmetry to form the heterotetrameric 2:2 antitoxin:toxin
complexes (Figures 1A and 1F). The heterotetramers are exclu-
sively formed through interactions of the antitoxins plus one
additional hydrogen bond between the toxin and the opposing
antitoxin in the RelBE-2 structure (Arg-62 NH2 and Gln-56
OE1, respectively) (Figures 1A and 1F). The N-terminal globular
domains of the antitoxins interact nonspecifically to form an
extended six-stranded b sheet that is highly hydrophobic
(Figures 1B and 1G). Helices a-3 and a-30 also contribute to
the antitoxin dimer interface by interacting through hydrophobic
residues. These helices cross at an angle of35 to form a funnel
that accommodates large hydrophobic residues at the top of the
funnel and smaller side chains at the bottom of the funnel
(Figures 1A and 1F).
Phylogenetic Clustering
RelE toxins belong to a diverse toxin superfamily that includes
the RelE and YoeB toxins and has representatives in both
the archaea and bacteria. Because the overall fold of RelE/
YoeB toxins is conserved but protein function has significantly
diverged (Arbing et al., 2010), we constructed a phylogenetic
tree using sequences from those RelE-like proteins for which
structures have been determined. The goal is to identify aminoStructure 21acid residues that may be important for toxin activity (Figures
3A and 3B). The toxins assemble in two main clusters: the first
one contains the three Mtb RelE-like proteins and E. coli YoeB
(EcYoeB) while the second comprises the archaeal RelE toxins
and E. coli RelE (EcRelE). Within the first cluster, Mtb RelE-1
and RelE-2 toxins form a distinct subcluster while Mtb RelE-3
is located in a second subcluster with the extensively character-
ized EcYoeB, whose catalytic strategy has been elucidated
(Christensen et al., 2001; Christensen and Gerdes, 2003). The
relative distance among all three Mtb RelE-like proteins within
the primary cluster indicates a possible divergence in catalytic
mechanisms and target of action.
Structural Homolog Comparison of RelBE-3
Superposition of the structures of Mtb RelE-3 with EcYoeB
(Protein Data Bank [PDB] code 2A6Q) shows a root-mean-
square deviation (rmsd) of 2.4 A˚ for 78 a-carbon pairs with
26% sequence identity (Figure S2). The phylogenetic analysis
suggests that RelE-3 is more similar to YoeB than to the other
toxins of the RelE/YoeB superfamily. Consistent with this predic-
tion is the conservation of the YoeB residues implicated in its
catalytic mechanism (Zhang et al., 2003; Kamada and Hanaoka,
2005) in analogous positions in the RelE-3 toxin structure, which
suggests that RelE-3 cleaves RNA in a similar manner as
EcYoeB. The catalytic mechanism of RelE-3 would involve
Glu-47 acting as a general base and His-84 serving as the
general acid. A large rearrangement of the C-terminal domain
of RelE-3 upon antitoxin release would be required to bring
Glu-47 and His-84 into favorable conformations for catalysis.
Analogous to YoeB, the Mtb RelE-3 Arg-60 and/or Arg-65 resi-
dues would be involved in binding the RNA reactive phosphate
group (Zhang and Inouye, 2009). RelE-3 may thus be an incom-
plete endoribonuclease that binds to the A-site of the 70S ribo-
some to cleave mRNA using a mechanism analogous to that of
EcYoeB.
The structural homology between the toxins of the RelBE-3
complex and the YefM-YoeB complex extends to the antitoxin
structures as well (rmsd of 1.9 A˚ for the superposition of 74 Ca
with a sequence identity of 24%). The RelBE-3 interactions are
similar to those seen in the YefM-YoeB structure and thus
RelB-3 inhibits RelE-3 in the same manner as YefM-YoeB.
Structural Homolog Comparison of RelE-2
The phylogenetic tree (Figure 4A) based on sequence alignments
(Figure 4B) suggests that RelE-1 and RelE-2 form a separate
subcluster within their branch of the tree and thus may have
diverged from the other toxins in the cluster in terms of a catalytic
mechanism. A DALI search (Holm and Sander, 1995) using the
coordinates for RelE-2 identified close structural relationships
with EcYoeB and EcRelE toxins (Figures 4A and 4B) (Kamada
and Hanaoka, 2005; Zhang and Inouye, 2009).
Structural comparisons reveal a lack of conservation of func-
tionally important YoeB residues (Kamada and Hanaoka, 2005)
in equivalent positions in RelE-2. However, the YoeB Arg-65
believed to bind the RNA reactive phosphate group is conserved
in equivalent positions in Mtb RelE-1 and RelE-2 (Figure 4D;
RelE-1 Arg-62 and RelE-2 Arg-61) and thus could also play this
role in RelE-1 and RelE-2 (Figure S3). The nonconservation of
the residues that act as the YoeB general acid and base in Mtb, 627–637, April 2, 2013 ª2013 Elsevier Ltd All rights reserved 629
Figure 1. The Structures of Mtb RelBE-2 and Mtb RelBE-3
N and C termini are indicated by N or C, respectively. Antitoxins are shown in green and cyan and toxins are shown in magenta and orange. Secondary structure
elements are marked with an apostrophe.
(A and F) Ribbon diagrams of the RelBE-2 and RelBE-3 heterotetramers, respectively. The single hydrogen bond formed between RelB-2 of one heterodimer and
RelE-2 of the symmetry-related molecule is represented as a blue dotted line. Secondary structure annotations are shown in black for antitoxins and in red for
toxins.
(B and G) Top view of the ribbon diagram of the heterotetramers. Conserved basic residues are likely to be involved in DNA binding are shown as blue sticks.
(C and H) Surface potential representation of the RelBE-2 and RelBE-3 heterotetramers showing the antitoxin DNA-binding domain.
(D and I) Bottom view of the ribbon diagrams showing antitoxin helices a-4 and a-5 that envelop the toxins.
(E and J) Ribbon diagram of RelE-2 and RelE-3 and stick representation of putative substrate binding and catalytic residues.
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Proteomics of the Three Mtb RelBE TA ComplexesRelE-1 and RelE-2 suggests that these toxins use an alternative
RNA cleavage mechanism consistent with the differences in
toxin-mediated cell growth arrest seen in this study and that of
Korch et al. (2009).
Our search for RelE-2 structural homologs also identified
two archaeal RelE toxins, Pyrococcus horikoshii aRelE (PDB
code 1WMI) and Methanococcus jannaschii MjRelE (PDB code
3BPQ), whose structures were determined in complex with their
cognate antitoxins aRelB andMjRelB, respectively (Takagi et al.,
2005; Francuski and Saenger, 2009).While the toxins share an
equivalent core structure (rmsdaRelE-RelE-2 = 1.8 A˚, 75 Ca pairs,
27% sequence identity, Z score = 10.9; rmsdMjRelE-RelE-2 =
2.2 A˚, 72 Ca pairs, 22% sequence identity, Z score = 9.3), the
antitoxins have a completely unrelated fold and therefore bind
their cognate toxin partners in a different manner (Figure 4A).
Strikingly, despite the differences in the fold and sequences of630 Structure 21, 627–637, April 2, 2013 ª2013 Elsevier Ltd All rightsthe Mtb and archaeal antitoxins, there is strong conservation
of three of the five functionally important aRelE residues in anal-
ogous positions in all four toxins (Figures 4 and 5). These resi-
dues (RelE-1: Leu-49, Ser-58, and Arg-62; RelE-2: Leu-45,
Ser-54, and Arg-61; aRelE: Leu-48, Arg-58, and Arg-65;MjRelE:
Ile-47, Arg-55, and Ser-62) mediate TA interactions and play
key roles in the TA interface. The other two aRelE residues
(Arg-40 and Arg-85) implicated as crucial for aRelE function
are conserved in structurally analogous positions in RelE-1
(Arg-44 and Arg-85) and RelE-2 (Arg-40 and Arg-81). However,
the side chains of these arginine residues do not strictly superim-
pose in the RelE-2 and aRelE structures, most likely because
these are solvent exposed, disordered, and lacking observed
density for the side-chain atoms (Figure 4A). An equivalent
residue to aRelE Arg-40 is missing in MjRelE but aRelE residue
Arg-85 is conserved as Arg-80 in MjRelE. It is noteworthy thatreserved
Figure 2. Superposition of the Structures of Mtb RelE-like Toxins
and Mtb YefM-like Antitoxins
RelBE-2 is shown in red and RelBE-3 in gray.
(A) Ribbon diagram of the crystal structures of RelE-2 and RelE-3.
(B) Ribbon diagram of the crystal structures of RelB-2 and RelB-3.
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Proteomics of the Three Mtb RelBE TA Complexesin the structure of MjRelE Arg-62, which is conserved in analo-
gous positions in aRelE, Mtb RelE-1, and RelE-2 and proposed
to mediate RNA cleavage, was spontaneously mutated to a
serine. In the structure, MjRelE Ser-62 does not directly interact
with MjRelB but an arginine side chain at this position would
make a direct interaction with the antitoxin as observed in the
aRelBE and Mtb RelBE-2 structures.
Further structural comparison of the structures of aRelE,
MjRelE, and Mtb RelE-2 in complex with their respective part-
ners identifies two additional arginine residues that are con-
served in all three structures (RelE-2: Arg-56 and Arg-77;
RelE-1: Arg-57 and Arg-76; aRelE: Arg-60 and Arg-81; and
MjRelE: Arg-57 and Arg-76). aRelE Lys-47, MjRelE Lys-45, and
Mtb RelE-2 Lys-43 also interact with their cognate antitoxins
and thus may play a role in mediating TA interactions (Figures
4A and 4B).
The structure of EcRelE solved in complex with the Thermus
thermophilus 70S ribosome (PDB code 3KIS) sheds light on
the RelE-induced RNA cleavage mechanism (Neubauer et al.,
2009). The overall structures of EcRelE and the two Mtb RelE
toxins are conserved (rmsdEcRelE-MtbRelE-2 = 1.9 A˚ on 75 Ca,
20% sequence identity, Z score = 10.1; rmsdEcRelE-MtbRelE-3 =
2.0 A˚ on 75 Ca, 16% sequence identity, Z score = 9.3) but only
EcRelE arginine residues Arg-61, which stabilizes the interme-
diate, and Arg-81, which acts as a general acid, are strictly
conserved in Mtb RelE-1 and RelE-2 (corresponding residues:
RelE-1, Arg-62 and Arg-80; RelE-2, Arg-61 and Arg-81) (Figure 4;
Figure S3).
RelE-2 Expression Results in AlteredMycobacterial Cell
Morphology
Expression ofMtb RelE-1 and RelE-2 toxins have similar effects
on cell viability (Figure S1) and sequence alignments suggest
that these toxins share a common catalytic mechanism and
are likely to be functionally redundant. To further explore the
effects of this subclass of RelE toxins on mycobacterial physi-
ology, we examined the effects of RelE-2 expression. The
RelE-2 toxin was successfully expressed in M. smegmatis,
a tractable mycobacterial model system. The control strain
grew normally and the cell morphology was consistent with
typical M. smegmatis cell morphology (Figure 5A). RelE-2Structure 21expression was found to result in abnormal cell growth charac-
terized by the presence of elongated filamentous cells about
2.5 times the length of normal M. smegmatis cells (Figure 5B;
Movie S1). Coexpression of the RelB-2 antitoxin resulted in
normal cell morphology, indicating the effect is toxin mediated
(Figure 5C).
RelE-2 Expression Enhances Mycobacterial Survival
upon Antibiotic Exposure
The influence of RelE-2 expression onM. smegmatis drug toler-
ance was evaluated by exposing the cells to lethal doses of the
antituberculous antibiotics ofloxacin (OFX), rifampicin (Rif), or
isoniazid (INH). Strikingly, expression of RelE-2 in cells exposed
to a lethal dose of OFX (ten times theminimum inhibitory concen-
tration) resulted in a 100-fold increase in the number of viable
cells at 30 hr after antibiotic exposure (Figure 6A). RelE-2 expres-
sion had only a modest effect on cell survival at the 30 hr time
point for cells exposed to the antibiotics Rif and INH. However,
there was a significant effect on the killing kinetics compared
to the cells harboring the empty expression vector (Figures 6B
and 6C). A 10-fold increase in survival was observed for the
RelE-2-expressing cells exposed to both Rif and INH during
the first 20 hr of the respective treatments, but at the end of
the 30 hr time course a similar decrease in the colony-forming
unit of the cells was observed for both drugs. To verify that the
increased survival rate was RelE-2 dependent, a Mtb H37Rv
RelE-2 deletion mutant was constructed by specialized trans-
duction (Bardarov et al., 2002) and the effect of the RelE-2 dele-
tion on cell survival upon antibiotic exposure was determined
(Figures 6D–6F). OFX or a combination treatment of INH and
Rif resulted in a log-lower survival at the end of 4 days for
DRelE-2 in comparison to H37Rv (Figures 6E and 6F). However,
no difference in the killing kinetics of DRelE-2 in comparison to
H37Rv was observed after INH or Rif treatment. Because it has
been documented that rel homologs are expressed after infec-
tion of Mtb in macrophages (Korch et al., 2009), mc23403
(expresses an empty vector), mc23404 (expresses RelE-2), and
mc23405 (expresses RelBE-2) strains were used to infect
a human acute monocytic leukemia THP.1 cell line (Figure 7).
In the uninduced condition, all three strains resulted in a similar
macrophage death as determined by subG1 analysis. A short
induction of either RelE-2 or RelBE-2 decreased the macro-
phage cell death from 72.2% (mc23403) to 33% (mc23404) and
25.9% (mc23405), respectively. A longer induction of RelE-2 or
RelBE-2 did not significantly alter the result compared to the
short induction and cell death of 79.3%, 40.1%, and 37.8%
was observed in cells infected with mc23403, mc23404, and
mc23405, respectively.
DISCUSSION
Our structures of theMtb RelBE family of complexes reveal that
the overall folds of the individual toxins and antitoxins are well
conserved with the superfamilies RelE/YoeB and YefM, respec-
tively, to which these proteins belong (Francuski and Saenger,
2009). The overall architecture of the Mtb complexes is also
conserved as revealed by the heterotetrameric crystal structures
of RelBE-2 and RelBE-3. However, significant differences in
putative catalytic residues of the toxins, identified by structural, 627–637, April 2, 2013 ª2013 Elsevier Ltd All rights reserved 631
Figure 3. Phylogenetic Tree of RelE-like Protein Homologs based on Protein Sequence Multialignment
(A) A phylogenetic tree was generated from a multiple sequence alignment prepared with CLUSTALW (Thompson et al., 1994) using the Phylogeny.fr server
(Dereeper et al., 2008).
(B) Sequence alignment corresponding to the three main clusters of the phylogenetic tree.
Structure
Proteomics of the Three Mtb RelBE TA Complexesand sequence comparisons, suggest that RelE-1 and RelE-2
employ a distinct catalytic mechanism from their closely related
counterpart RelE-3 to exert toxicity.
The dimeric N-terminal domains of the RelB-2 andRelB-3 anti-
toxins, as in the structurally homologous YefM and Phd anti-
toxins, form a positively charged structure consistent with the
reported DNA-binding activity of the antitoxins that is required
for autoregulation of transcription of the TA operon (Kamada
and Hanaoka, 2005; Garcia-Pino et al., 2010). Structural align-
ments of our RelB-2 and RelB-3 structures and the sequence
comparison with Mtb RelB-1 show the conservation of arginine
residues in RelB-3 and RelB-1 and lysine residues in RelB-2, at
equivalent positions (Figures 1A, 1B, 1F, 1G, and 2B). The substi-
tution of lysine residues, whose acetylation results in stronger
DNA binding and more stringent control of operon expression
(Bahassi et al., 2011), for arginine residues may be a biological
adaptation used by Mtb to modulate activity of the numerous
TA complexes encoded within its genome.
Despite dramatic differences in backbone fold and sequence
of the antitoxins that neutralize RelE-like toxins in the com-
plex structures of Mtb RelBE-2, P. horikoshii aRelBE and
M. jannaschii MjRelBE, the same conserved toxin residues are
shielded in the interaction (Figures 4C and 4D). We can postulate
that these residues are not only conserved because they
mediate the protein-protein interactions governing TA complex
formation but that they may also be involved in RNA substrate
binding and/or in the catalytic activity of these RelE ribonucle-
ases. Although RelE has been shown to require association
with the ribosome for full activity, it is likely that crucial residues
involved in the catalytic mechanism of RNA degradation may still
need to be protected to prevent nonspecific RNA degradation
(Christensen and Gerdes, 2003). We propose that Mtb RelE-2
Arg-56 and Arg-61, which are also conserved in Mtb RelE-1 as
Arg-60 and Arg-65, are likely to be involved in stabilizing the
negative charge of the RNA phosphate groups, as shown by632 Structure 21, 627–637, April 2, 2013 ª2013 Elsevier Ltd All rightsa spontaneous mutation, that abolish the toxicity of MjRelE.
Additional residues, identified through structural comparisons,
likely to be involved in RelE-like protein toxicity are RelE-2 Lys-
43, Leu-45, Ser-54, and Arg-77. It is noteworthy that these
residues are also conserved inMtb RelE-1, but the lack of crys-
tal structure for the Mtb RelBE-1 complex prevents us from
describing the TA interactions in detail (Figure 4D).
The filamentation/elongation of Mtb was previously observed
for cells growing in macrophages after infection (Chauhan et al.,
2006) and correlates well with the expression profile of rel genes
during intracellular growth (Korch et al., 2009). Inhibition of
macrophage cell death after Mtb infection plays a central role
in tuberculosis disease pathogenesis (Hinchey et al., 2007).
Our observation thatM. smegmatis expressingMtb RelE-2 toxin
suppresses macrophage-mediated bacterial cell death sug-
gests that this TA system may represent anotherMtb cell-death
suppression mechanism. The observed phenotype suggests
that RelE-2 may target RNAs encoding proteins involved in cell
division, thus resulting in elongated cells (Figure 5B). However,
further work is required to determine the role of RelE-2 in cell
elongation, the prevention of macrophage cell death, and intra-
cellular Mtb survival.
The large diversity in the families of TA complexes rises from
partner switching allowed by the modularity in antitoxin struc-
ture. The folds of the Mtb RelE-like toxins are very similar to
both archaeal and bacterial RelE-like toxins. However, the folds
of theMtb RelB-1, RelB-2, and RelB-3 antitoxins are completely
unrelated to the RelB proteins of the archaeal and bacterial
RelBE systems and are instead structurally similar to the YefM-
like antitoxins. The RelBE-2 and RelBE-3 complexes are thus
derived from mixing between major classes of the RelE super-
family of toxins and the PhD/YefM antitoxin superfamily (Anan-
tharaman and Aravind, 2003).
Our toxicity data show that Mtb RelE-like proteins are not
equally toxic and these differences can be attributed to thereserved
Figure 4. Superposition of the Structure of Mtb RelBE-2 with Its Structural Homologs
In all figures, Mtb RelB-2 is shown in magenta, Mtb RelE-2 is in green, aRelE is in pink, aRelB is in black, MjRelE is in blue, and MjRelB is in red. Functionally
important residues are shown as green (Mtb RelE-2), pink (aRelE), or blue sticks (MjRelE).
(A) Superposition of Mtb RelBE-2 and aRelBE.
(B) Superposition of Mtb RelBE-2 and MjRelBE.
(C) Structure-based sequence alignment ofMtbRelE-2 with aRelE,MjRelE, andMtbRelE-1. Side chains of the residues that interact with the antitoxins are shown
in bold and colored according to the structure to which they belong. The red boxes highlight residues for which interactions with the antitoxins are conserved.
(D) Summary of the residues that are conserved in the structures of aRelE,MjRelE,Mtb RelE-2, RelE-1, and EcRelE. Shaded rows highlight residues that interact
with residues of the antitoxins. Residues shown to be crucial for toxicity in other studies are indicated in the last column.
NC, not conserved. See also Figures S2 and S3.
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Proteomics of the Three Mtb RelBE TA Complexesvariation in functionally important catalytic residues. RelE-3 is
likely to use a similar mechanism as EcYoeB, with RelE-3
residues Glu-47 and His-84 serving as the general acid and
base and Arg-60 and/or Arg-65 binding the RNA reactive phos-
phate group (Kamada and Hanaoka, 2005; Figure 4D). In our
M. smegmatis toxicity experiment, RelE-3 expression was
shown to be mildly toxic, only slightly retarding cell growth,
which correlates with the limited effect of YoeB expression
on the colony-forming ability of wild-type E. coli (Christensen
et al., 2004). Mtb RelE-1 and RelE-2 have catalytic residues
conserved in analogous positions and are both extremely toxic,
suggesting that they share a common mechanism. In vivo MtbStructure 21killing assays indicate that these toxins may be functionally
redundant because no difference in the killing kinetics of
the mutant compared to the wild-type was observed in the
DrelE-2 strain to INH and Rif (Figures 6E and 6F). However, the
presence of expressed RelE-2 is advantageous toMtb because
it protects the cells against the antibiotics Rif and INH for short
periods of up to 20 hr (Figures 6B and 6C) andRelE-2-expressing
M. smegmatis had higher short-term survival rates in macro-
phages (Figure 7). Considering the redundancy of toxin-
encoding genes in the Mtb genome, it is not surprising that
the suppression of one toxin gene has little effect. How-
ever, the short-term protection against antibiotics after RelE-2, 627–637, April 2, 2013 ª2013 Elsevier Ltd All rights reserved 633
Figure 5. Micrographs of M. smegmatis
Cells
(A) Control: M. smegmatis mc23403 expressing
the empty pYUB1485 vector.
(B) Expression of RelE-2 (mc23404) results in cell
elongation in M. smegmatis.
(C) The elongation phenotype upon RelE-2
expression is neutralized by RelB-2 coexpression
(mc23405).
See also Figure S1.
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Proteomics of the Three Mtb RelBE TA Complexesoverexpression may not accurately reflect the in vivo effects of
stress-induced toxin expression. It is likely that the survival capa-
bility ofMtb is linked to a network of mechanisms for which each
individual toxin may make only a modest contribution.
Our studies have revealed the structural similarities of theMtb
RelE-like TA systems and have highlighted the specific structural
features that are the basis for the differences in toxicity seen
between RelE-3, which is only mildly toxic, and RelE-2 and
RelE-1, which are acutely toxic. RelE-2 expression was found
to have an effect on cell division, resulting in elongated cells,
which is likely linked to the decreased antibiotic susceptibility
of RelE-2-expressing cells. Similar to other TA complexes, the
antitoxin molecules interact with their toxins so as to occlude
the catalytic residues of the toxins and thus prevent accidental
toxicity.
The variations in toxin-mediated toxicity between structurally
related toxin family members may allow for fine-tuning of
the bacterial response to different stresses and/or regulatory
controls, thus resulting in toxin-dependent effects on microbial
growth. If the functional diversity of the Mtb RelE-like toxin
family is extended to the other TA systems encoded in the Mtb
genome, then it would form an extremely complex stress-
response network that is likely the key component of the ability
ofMtb to respond and adapt to the transiently harsh environment
in which it resides.
EXPERIMENTAL PROCEDURES
Construction of the RelBE-2 and RelBE-3 Coexpression Vectors
The individual genes encoding the RelBE-2 or RelBE-3 TA complexes were
cloned into the pET46-Ek/LIC plasmid using the LIC minimal adaptor (both
from Novagen, Gibbstown, NJ) such that toxin and antitoxin are coexpressed
from the same vector with a cleavable affinity tag appended to the toxin.
Additional description of cloning procedures is provided in Supplemental
Information.
Protein Expression and Purification
SeMet-labeled RelBE-2 complex was produced by following the protocol of
Van Duyne et al. (1993). Complex expression in E. coli BL21(DE3) was induced
by 1 mM IPTG for 5 hr at 37C. The cell pellet was resuspended in buffer A
(20 mMTris [pH 8.0], 300mMNaCl, 10 mM imidazole, 10%glycerol containing
1X Bugbuster [Novagen, Gibbstown, NJ]) and lysed using a French press.
The complex was purified by Ni-NTA affinity chromatography and the pure
SeMet-labeled RelBE-2 complex concentrated to 6 mg/ml for crystallization
screening.
Native and SeMet-labeled RelBE-3 complexeswere both produced in E. coli
Rosetta (DE3). SeMet-labeled RelBE-3 was produced using the protocol of
Van Duyne et al. (1993). Protein expression was induced by the addition of
IPTG to 0.75 mM or 1 mM and cells grown for 5 hr at 37C or overnight at
20C for SeMet-labeled and native protein complexes, respectively.
Cell pellets for both native and SeMet-labeled RelBE-3 protein complexes
were resuspended in buffer C (20 mM Tris [pH 8.0], 300 mM NaCl, 10 mM634 Structure 21, 627–637, April 2, 2013 ª2013 Elsevier Ltd All rightsimidazole, and 10% glycerol) and lysed by French press. The complexes
were purified by Ni-NTA affinity chromatography and then dialyzed against
20 mM HEPES (pH 8.0), 300 mM NaCl, and 10% glycerol. Reductive methyl-
ation of the native complex was then performed (Shaw et al., 2007). The
complexes were further purified using a Superdex S-200 equilibrated in buffer
E (buffer C without imidazole) and were concentrated to 20 mg/ml for crystal-
lization screening. Additional details on protein expression and purification are
described in Supplemental Information.
Crystallization and Data Collection
Diffraction quality crystals of SeMet RelBE-2 were obtained in 25% PEGMME
2,000 and 0.15 M potassium thiocyanate. Strongly diffracting crystals of
SeMet RelBE-3 were obtained using 0.1 M Tris (pH 8.9), 0.1 M NaCl, 24%
PEG 10,000, and 20% glycerol at a protein concentration of 7 mg/ml. Diffrac-
tion quality crystals of the methylated native RelBE-3 complex were obtained
in 0.1 M sodium citrate tribasic dehydrate (pH 5.6), 20% 2-propanol, and 20%
w/v PEG 4,000. All crystals were flash frozen in liquid nitrogen and data were
collected at beamline 24-ID-C of the Advanced Photon Source (Table 1). All
data were processed using DENZO and SCALEPACK (Otwinowski and Minor,
1997).
Structure Determination and Refinement
The structures of SeMet-RelBE-2 and SeMet-RelBE-3 were solved by SAD.
The program HKL2MAP (SHELXC, D and E) (Schneider and Sheldrick, 2002;
Sheldrick, 2002) was used to determine the substructures and the experi-
mental phases were improved by density modification using the program
DM (Cowtan, 1994). Initial models of the RelBE-2 and RelBE-3 complexes
were automatically built with ARP/wARP (Perrakis et al., 1999) and phenix.
autobuild (Terwilliger et al., 2008), respectively, and additional residues were
built manually using the program Coot (Emsley and Cowtan, 2004). The struc-
tures were refined with Refmac (Murshudov et al., 1999), for RelBE-2, or
phenix.refine (Afonine et al., 2005), for RelBE-3. The structure of the native
RelBE-3 complex was solved by molecular replacement with the program
Phaser (McCoy et al., 2007) using the SeMet-labeled RelBE-3 structure as
a search model. Data collection and refinement statistics are summarized in
Table 1. The geometry of the structures was checked using the SAVES
Server (http://nihserver.mbi.ucla.edu/SAVES). Structure figures were pre-
pared with PyMOL (The PyMOL Molecular Graphics System version
1.2r3pre, Schro¨dinger) and structural superpositions with the FATCAT server
(Ye and Godzik, 2004).
Sequence Alignment
Sequence alignments were generated with T-coffee (Notredame et al., 2000)
and Expresso (Armougom et al., 2006) with protein sequences obtained
from WebTB (http://www.webtb.org).
Cloning and Expression of Mtb Toxin Genes for M. smegmatis
Toxicity Assays
M. smegmatis mc24517 was used as the expression strain and pYUB1213,
derived from pYUB1062 as described in the Supplemental Information,
was used as the expression vector (Wang et al., 2010). Plasmids contain-
ing individual toxin genes were electroporated into mc24517 or mc2155.
Cells were plated on 7H10 plates containing kanamycin (20 mg/ml), and
hygromycin B (100 mg/ml) in the presence and absence of the inducing
agent (0.2% [w/v] acetamide). The plates were incubated at 37C for
3 days and were scored for the presence or absence of colonies inreserved
Figure 6. RelE-2 Confers Drug Tolerance to Mycobacterial Cells
(A–C) M. smegmatis mc23403, mc23404, and mc23405 were treated with (A) OFX, (B) Rif, and (C) INH in the presence and absence of the RelE-2 expression
inducer acetamide (Ace).
(D) Southern blot confirming the deletion of relE-2 inMtb H37Rv (mc23406). Expected size for H37Rv (WT) and H37Rv DrelE-2 are indicated (arrows).Mtb H37Rv
and DrelE-2 strain m1 (mc23406) were treated with either (E) OFX or INH and with (F) Rif alone or Rif and INH. The death kinetics in the presence of drug is plotted
as percent survival with respect to time.
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Proteomics of the Three Mtb RelBE TA Complexescomparison with the pYUB1062 vector control and the colonies obtained
from mc2155.
The relE-2 and relBE-2 genes were cloned into vector pYUB1485 (contain-
ing acetamidase promoter) to generate pYUB1486 and pYUB1487, respec-
tively. The pYUB1485, pYUB1486, and pYUB1487 plasmids were transformed
into M. smegmatis mc2155 to obtain mc23403, mc23404, and mc23405,
respectively. The colonies obtained were grown at 37C to an A600 = 0.5–0.6
in 7H9 medium supplemented with 0.05% Tween 80, 10% OADC, and
0.05% glycerol before induction with 0.2% acetamide. The cells were
observed after 12 hr with a microscope at 3100 magnification to compare
cell morphology.
Mtb H37Rv Antibiotic Challenge Experiment
To determine killing kinetics overnight cultures of A600 = 0.8 were diluted to
A600 = 0.1 in 10 ml of 7H9 media with and without inducer (acetamide) and
treated with INH (100 mg/ml), Rif (100 mg/ml), or OFX (100 mg/ml). The
deletion mutant of relE-2 (mc23406) was generated in Mtb H37Rv using
specialized transduction and confirmed by Southern blot (Bardarov et al.,
2002). Killing kinetics for Mtb H37Rv and Mtb mc23406 were determined
by diluting cultures of A600 0.8 to A600 = 0.1 in 10 ml of 7H9 media
and treated at the following antibiotic concentrations: INH (1 mg/ml), Rif
(5 mg/ml), and OFX (10 mg/ml). All samples were taken at various intervalsStructure 21and various dilutions were plated in triplicate on 7H10 plates to obtain the
colony-forming units.
THP1 and Human Cell Infection Protocol
THP.1 cells were differentiated into adherent macrophages by resuspension in
complete RPMI media (Invitrogen, containing 10% fetal bovine serum and
55 mM beta-mercaptoethanol) containing 50 nM PMA (phorbol 12-myristate
13-acetate) at a concentration of 1 million cells per milliliter. After a 24 hr
incubation, media was changed to complete RPMI media containing 5%
non-heat-inactivated human serum. Adherent THP.1 cells were infected with
mycobacteria strains at a multiplicity of infection of 5:1 for 2 hr. Infected
THP.1 monolayers were left in complete RPMI media, incubated at 37C for
72 hr, and then harvested for subG1 analysis.
SubG1 Analysis of THP.1 Cell Death
An adapted procedure from Riccardi and Nicoletti (2006) was followed. Briefly,
at various times postinfection, mycobacteria-infected THP.1 cells were har-
vested, centrifuged, and fixed in 500 ml ice-cold 70% ethanol and incubated
overnight at20C. Cells were then resuspended in 200 ml PI staining solution
(0.1% Triton X-100, 20 mg/ml propidium iodide, 200 mg/ml RNase A) and
analyzed by flow cytometry (BD FACSCalibur) for propidium iodide (FL2)
fluorescence., 627–637, April 2, 2013 ª2013 Elsevier Ltd All rights reserved 635
Figure 7. Overexpression of RelE-2 in M. smegmatis Results in
Suppression of Cell Death in infected THP.1 Macrophages
THP.1 cells were infected at a multiplicity of infection of 5:1 with strains
mc23403, mc23404, and mc23405 that had been grown for 3 hr or 24 hr in the
presence of 0.2% acetamide (to induce RelE-2 expression). At 72 hr post-
infection, THP.1 cells were harvested and percent cell death determined by
SubG1 analysis and flow cytometry.
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The atomic coordinates and structure factors for RelBE-2 and RelBE-3 have
been deposited in the Protein Data Bank with the accession codes 3G5O
and 3OEI, respectively.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures, Supplemental Results, one
movie, and three 3Dmolecular models and can be found with this article online
at http://dx.doi.org/10.1016/j.str.2013.02.008.
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